Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).
The clinical symptomatology of the Zollinger-Ellison syndrome and the pathologic anatomy of gastrinomas are reviewed. Experience with 17 patients with the Zollinger-Ellison syndrome is presented with special reference to stimulation tests (secretin, glucagon, calcium infusion, test meal) and to localization and immunohistologic, ultrastructural, and biochemical findings in gastrinomas. Multiple hormone production by the tumors is frequent. The ultrastructure and the Sephadex G-50 gel filtration patterns of immunoreactive gastrin in sera and tumors are not uniform and are not related to localization of the tumors in the pancreas or duodenum or to the gastrin concentration. Hyperplasia of the pancreatic islets is a frequent finding in gastrinoma patients, suggesting that hypergastrinemia may stimulate islet growth.
D000951:Antigens, Neoplasm / Q000032:analysis; D002118:Calcium; D002850:Chromatography, Gel; D004379:Duodenal Neoplasms / Q000032:analysis / Q000175:diagnosis / Q000473:pathology; D004435:Eating; D005755:Gastrins / Q000032:analysis / Q000097:blood / Q000276:immunology; D005934:Glucagon / Q000032:analysis; D006801:Humans; D007106:Immune Sera; D007328:Insulin / Q000032:analysis / Q000276:immunology; D007413:Intestinal Mucosa / Q000473:pathology; D007515:Islets of Langerhans / Q000473:pathology; D008207:Lymphatic Metastasis; D008854:Microscopy, Electron; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000032:analysis / Q000175:diagnosis / Q000473:pathology; D011863:Radioimmunoassay; D012633:Secretin; D013194:Staining and Labeling; D015043:Zollinger-Ellison Syndrome / Q000032:analysis / Q000175:diagnosis / Q000473:pathology*
D000951:Antigens, Neoplasm; D005755:Gastrins; D007106:Immune Sera; D007328:Insulin; D012633:Secretin; D005934:Glucagon; D002118:Calcium